Cell and Gene Therapy Made Easy

Limula SA

Incorporated

06.11.2020

Headquarters

Epalinges, Lausanne

Support

Limula is a Swiss company providing a cell processing platform for the production of highly personalised Cell & Gene Therapies (CGT). These 'living drugs' are the first truly curative treatments. But CGT will only revolutionise healthcare if they can be made in large enough quantities to reach the millions of patients in need. Limula’s proprietary solution increases overall safety, reproducibility and scalability of cell therapy manufacturing. By combining our expertise and a versatile tool, we support the rapid and cost-effective development of cell therapy products facilitating the transition from R&D to commercial-scale production. Our explicit mission is to help make the most personalized cancer treatments available to the patients in need, at reasonable cost, wherever they are.